Blue Torch Medical Technologies

Blue Torch Medical Technologies is a medical device company that developed a novel laser-based surgical system for treating Benign Prostatic Hyperplasia (BPH). Its flagship product, the Blue Torch, utilizes a specific wavelength of blue laser energy to perform precise tissue ablation and resection of the prostate. This technology was designed to offer urologists a more controlled and efficient alternative to traditional electrosurgical or other laser-based methods. The company was founded by experienced medical device entrepreneur James Stubbs and was acquired by Urotronic in 2020. Following Urotronic's subsequent acquisition by Laborie Medical Technologies, the Blue Torch technology remains a key component of their interventional urology portfolio.